Health-related quality of life (HRQL) in patients with advanced cutaneous squamous cell carcinoma (CSCC) treated with cemiplimab: Post hoc exploratory analyses of a phase II clinical trial. Migden, M., Rischin, D., Sasane, M., Mastey, V., Pavlick, A., Schmults, C. D., Chen, Z., Guminski, A., Hauschild, A., Bury, D., Chang, A. S., Rabinowits, G., Ibrahim, S. F., Lowy, I., Fury, M. G., Li, S., Chen, C. AMER SOC CLINICAL ONCOLOGY. 2020

View details for Web of Science ID 000560368300139